Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyphenon E in Asymptomatic CLL
NCT00262743Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2005
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of green tea extract in chronic lymphocytic leukemia (CLL), sponsored by Mayo Clinic. Primary endpoints: Confirmed Response Rate (CR and PR) at 6 months and Biological Response Rate at 6 months. Started Aug 2005; status: completed.
02
Drugs
green tea extract
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00262743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262743.